Atlas FDA

ARCHITECT HBsAg Qualitative / HBsAg Qualitative Confirmatory, Alinity i HBsAg Qualitative II / HBsAg Qualitative II Conf

FDA premarket approval P110029/S042 · decided 2023-10-11

Approval details

PMA number
P110029
Supplement
S042
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
ARCHITECT HBsAg Qualitative / HBsAg Qualitative Confirmatory, Alinity i HBsAg Qualitative II / HBsAg Qualitative II Conf
Applicant
Abbott Laboratories
Date received
2023-05-08
Decision date
2023-10-11
Days to decision
156 days
Decision code
APPR
Advisory committee
Microbiology
Expedited review
No
Location
Abbott Park, IL
Statement
Approval for the formulation change for the common accessories Pre-Trigger and Trigger, and storage condition changes for Pre-Trigger, used on ARCHITECT i2000SR, ARCHITECT i1000SR and Alinity i analyzer.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Anti-HCV Next (K252424)Abbott Laboratories2026-04-28
ARCHITECT iGentamicin (K243500)Abbott Laboratories2025-07-09
Alinity i Rubella IgG (K243168)Abbott Laboratories2025-06-20
Alinity h-series System (K243283)Abbott Laboratories2025-02-20
Alinity i Toxo IgM (K233932)Abbott Laboratories2024-08-30
TBI (K232669)Abbott Laboratories2023-09-29
HAVAb IgG II (K222850)Abbott Laboratories2023-08-10
Alinity h-series System (K220031)Abbott Laboratories2023-08-04